secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2024-11-20T23:59:59+00:00
Accession:  0001193125-24-262222
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health outlines 2025-27 growth plan; warns of 2024 EBITDA risk from USD strength
--------------------------------------------------------------------------------

- Targets organic revenue CAGR of 5-7% and adjusted EBITDA CAGR of 5-8% for 2025-2027.
- Aims to expand adjusted EBITDA margins by at least 50 bps and generate cumulative FCF >$500M.
- Sees serviceable addressable market of $18B; highlights strategic positioning and durable customer relationships.
- Notes risk that 2024 Adjusted EBITDA could fall modestly below guidance due to recent USD strengthening.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000119312524262222/0001193125-24-262222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000119312524262222/d874127d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-262222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer